about
sameAs
A perspective on the developmental toxicity of inhaled nanoparticlesSingle-Walled Carbon Nanotubes Inhibit the Cytochrome P450 Enzyme, CYP3A4.Epoxy composite dusts with and without carbon nanotubes cause similar pulmonary responses, but differences in liver histology in mice following pulmonary depositionIn vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in ratsMulti-walled carbon nanotube physicochemical properties predict pulmonary inflammation and genotoxicityElemental analysis of histological specimens: a method to unmask nano asbestos fibersCarbon Nanotube Emissions from Arc Discharge Production: Classification of Particle Types with Electron Microscopy and Comparison with Direct Reading TechniquesGenotoxicity of TiO2 nanoparticles assessed by mini-gel comet assay and micronucleus scoring with flow cytometryMechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell linesCancer Biology, Toxicology and Alternative Methods Development Go Hand-in-HandKeeping it real: The importance of material characterization in nanotoxicologyReliable nanomaterial classification of powders using the volume-specific surface area method.High throughput toxicity screening and intracellular detection of nanomaterialsPooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.Impact of nanosilver on various DNA lesions and HPRT gene mutations - effects of charge and surface coatingTowards a nanospecific approach for risk assessment.Suitability of analytical methods to measure solubility for the purpose of nanoregulation.Evaluation of the cytotoxic and genotoxic effects of benchmark multi-walled carbon nanotubes in relation to their physicochemical properties.Is the toxic potential of nanosilver dependent on its size?Systematic investigation of the physicochemical factors that contribute to the toxicity of ZnO nanoparticles.Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release.Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 1: oral route.Nano-TiO2 penetration of oral mucosa: in vitro analysis using 3D organotypic human buccal mucosa models.NANoREG data logging templates for the environmental, health and safety assessment of nanomaterialsEvaluation of methods to determine adsorption of polycyclic aromatic hydrocarbons to dispersed carbon nanotubes.Silver nanoparticles as a medical device in healthcare settings: a five-step approach for candidate screening of coating agents.Relevance of Physicochemical Characterization of Nanomaterials for Understanding Nano-cellular Interactions.Are fluorescence-based chlorophyll quantification methods suitable for algae toxicity assessment of carbon nanomaterials?Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes.Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles.
P859
Q26864626-6802E413-5BA5-4DC6-917F-6656C6F33716Q27348354-F24A8968-D900-4AF9-A1AA-8D553B1FA022Q28383066-6084EF0F-40A3-4472-8FD2-B88A09942BDCQ28387077-B2C8D377-1DF7-47D8-8295-2978B7186A08Q28389167-6DD1A915-52A0-4133-89E6-0BDB30A87CF8Q28390086-E9B00B0E-BB2F-4842-80A4-89551A5B2D17Q28390994-5ACB39C3-7CD0-44CB-8CAC-145F63D45E4AQ28397109-65B9C00C-07C7-4429-8803-002DE2786AA0Q28397895-5D1261F7-7EAA-44C1-A854-0F8C79988F74Q28549191-29AB49E9-3224-4422-B9D1-BBC1664697D5Q28549425-0064bd28-4d9d-20c4-48da-bfe35b0add9fQ29248057-69131969-D2EB-4456-A1F5-6D4C40FF278BQ29248511-47D56600-DD12-4155-9A68-DDE24D3EB00AQ31018385-9BA6A81C-DE22-49ED-B56A-7F3DB3991328Q34486567-607954D5-6D73-4716-8C14-F7B3D5773BCCQ38379927-60977459-AB30-4DC6-8419-E2045B0254EBQ38498064-2AA23FC3-BB85-4A6F-8DF6-803A0B14FF36Q38738349-0A44DE5D-7BC7-421F-91CB-3C4C84FD8F55Q38932968-69B2E954-4C03-4CB9-911D-8CEC6A95D577Q39020371-FBD28242-38D4-4DB9-AB93-5C54B351D1E1Q39023812-92533704-C51B-42BB-A4CC-7A0F3F17FC41Q41694034-9FD61F24-6146-4EE6-8C26-4BF08ADC82D4Q41862370-1801BE10-DF9E-4861-A674-D140836A7002Q47341008-1dba03c7-4428-e351-5c09-815d0995846bQ47922302-FB83004A-1E94-401D-8CD1-1BE9325E15E3Q48094580-822639CC-3A10-4C1C-89AE-CA11EDE21C4FQ49910822-8F8AF2BB-CB26-4EC5-BF39-2E217CF35EDEQ51210200-837F0293-AF0C-46A8-98E2-14D87EB133DDQ51460083-A4410548-E86B-4075-B200-D2C5DCF9B22CQ55015792-B9BAFA7F-493E-4C3A-8C3D-E918241BC46D
P859
description
EC-funded research project
@en
name
NANoREG
@en
type
label
NANoREG
@en
altLabel
A common European approach to the regulatory testing of nanomaterials
@en
NANOREG
@en
prefLabel
NANoREG
@en
P17
P2769
49,586,318.23
P31
P3400
P580
2013-03-01T00:00:00Z
P582
2017-02-28T00:00:00Z